Cardiac Drug Therapy

Cardiac Drug Therapy

4.85 (7 ratings by Goodreads)
By (author) 

List price: US$249.01

Currently unavailable

We can notify you when this item is back in stock

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

Description

This book addresses the pharmacology and therapeutic application of drugs used to treat heart diseases and hypertension. Additions and updates to the sixth edition include six new chapters on current controversies in cardiac drug therapy such as the beta blocker issue many cardiologists are presently grappling with. The book provides practical advice on how to manage cardiac diseases and addresses the choice of one particular cardiac agent vs. another.show more

Product details

  • Hardback | 420 pages
  • 180.3 x 256.5 x 22.9mm | 1,043.27g
  • Humana Press Inc.
  • Totowa, NJ, United States
  • English
  • Revised
  • 7th ed. 2007
  • biography
  • 158829904X
  • 9781588299048
  • 1,388,210

Review quote

From the reviews of the seventh edition: "...summarizing the rapidly evolving pharmacologic options available for the treatment of cardiovascular disease." -Doody's Book Review, Weighted Numerical Score:92 - 4 Stars "...a valuable clinical reference" -Doody's Book Review, Weighted Numerical Score:92 - 4 Stars "This publication focuses on cardiac pharmacotherapy. The intended audience for this text includes cardiologists, internists, and medical residents. The author's intent is to help physicians understand the pharmacotherapy of various diseases and the differences within cardiovascular drug classes that impact drug selection. ... The references ... are reasonably updated and predominantly use tertiary sources. ... has many useful observations and more drug information than most physician-written books. ... This is an interesting book that provides decent clinical and clinical trial observations ... ." (C Michael White, The Annals of Pharmacotherapy, Vol. 41, 2007)show more

Table of contents

CONTENTS 1 Beta-Blockers: The Cornerstone of Cardiac Drug Therapy NEW CONCEPTS BETA-RECEPTORS MECHANISM OF ACTION DOSAGE CONSIDERATIONS PHARMACOLOGIC PROPERTIES AND CLINICAL IMPLICATIONS SALUTARY EFFECTS OF BETA-ADRENERGIC BLOCKADE BETA BLOCKERS VS CALCIUM ANTAGONISTS /NITRATES INDICATIONS FOR BETA-BLOCKERS ADVICE AND ADVERSE EFFECTS INDIVIDUAL BETA BLOCKERS WHICH BETA-BLOCKER TO CHOOSE Please LIST HEADINGS for all chapters 2. Beta blocker Controversies 1 3 Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers 53 Mechanism of Action, 55 ACE Inhibitors Versus Other Vasodilators, 57 Clinical Indications, 59 Contraindications, 64 Advice, Adverse Effects, Interactions, 65 Individual ACE Inhibitors, 67 Angiotensin II Receptor Blockers, 75 4. ACE Inhibitors Controversies 5 Calcium Antagonists (Calcium Channel Blockers) 81 Mechanism of Action, 81 Major Calcium Antagonists, 83 When to Choose a Calcium Antagonist, 93 Indications for Calcium Antagonists in the New Millennium, 94 Which Calcium Antagonist to Choose, 96 Combination of Calcium Antagonists with Beta-Blockers, Nitrates, or Digoxin, 98 6. Calcium Antagonists Controversies 7 Diuretics 103 Indications, 105 Thiazides, 106 Loop Diuretics, 106 Potassium-Sparing Diuretics, 112 Other Diuretics, 117 Potassium Chloride Supplements, 118 Important New Information from Clinical Trials, 123 8 Hypertension new headings to be up dated 127 Relevant Key Issues, 127 Definitions, 130 Nondrug Therapy, 133 Laboratory Work-Up, 134 Which Drugs to Choose, 134 Beta-Blockers, 148 Diuretics, 150 ACE Inhibitors and Angiotensin II Receptor Blockers, 155 Calcium Antagonists (Extended Release), 160 Centrally Acting Drugs, 163 Alpha1-Blockers, 164 Hypertensive Crisis, 166 9 . Hypertension Controversies 10 Management of Angina 179 Salient Clinical Features, 179 Treatment of Stable Angina, 180 Management of Unstable Angina, 194 Variant Angina (Prinzmetal's), 201 Recommendations, 203 11 Management of Acute Myocardial Infarction 209 New Terminology, 209 Therapeutic Implications, 209 Coronary Care Therapeutics, 216 Limitation of Infarct Size and Increased Survival, 221 Thrombolytic Therapy, 222 Beta-Blockers, 233 Nitrates, 235 Ace Inhibitors, 236 Statins, 237 Magnesium, 237 Management of Complications of Infarction, 238 Management of Non-ST-Elevation Myocardial Infarction, 248 12 Management of Heart Failure new headings to add 255 The Size of the Problem, 255 Diagnosis, 258 Basic Cause, 261 Factors Precipitating Heart Failure, 262 Pathophysiology, 263 Vasodilators, 265 Diuretics, 270 Beta-Blockers, 272 Inotropic Agents, 275 Drug Treatment of Systolic Heart Failure, 287 Management of Diastolic Heart Failure, 293 Management of Pulmonary Edema, 294 13. Heart Failure Controversies 14 Management of Cardiac Arrhythmias delete page numbers 301 Classification, 302 Diagnosis of Arrhythmias, 306 Management of Supraventricular Arrhythmias, 309 Ventricular Arrhythmias, 322 Ventricular Tachycardia, 324 Antiarrhythmic Agents, 328 Class IA, 328 Class IB, 333 Class IC, 337 Class II, 340 Class III, 342 15 Cardiac Arrest new headings 353 16 Management of Infective Endocarditis 375show more

Rating details

7 ratings
4.85 out of 5 stars
5 86% (6)
4 14% (1)
3 0% (0)
2 0% (0)
1 0% (0)
Book ratings by Goodreads
Goodreads is the world's largest site for readers with over 50 million reviews. We're featuring millions of their reader ratings on our book pages to help you find your new favourite book. Close X